Teledermoscopy and AI help review your skin spot images
Part of Cancer, Skin clinical trials.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a skin spot (lesion) looked at by a physician during a clinic visit
- Your physician must decide to send your case for teledermoscopy (image review)
- You must be able and willing to participate in the study
- You must be age 15 or older
- The study images must be clear enough for a doctor to review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests if a telemedicine tool can help find skin tumors early. It may be a good fit if you have a suspicious spot and light skin that burns easily.
This study uses special cameras and light to look at skin growths and help doctors diagnose skin cancer. It may be a way to better understand your skin without taking a sample.
This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.
This study tests whether an AI tool can help dermatologists more accurately identify skin lesions in images. It is for experienced dermatologists who regularly use dermoscopy.
This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.
Hear when a new Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.